Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Sertraline, an antidepressant, may rarely cause hair loss.

Ethosomes could improve how well skin treatments work, but more research is needed on their safety and stability.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Microneedling effectively helps deliver skin medications and is expected to improve with more research.

Valproate can cause brain swelling with high ammonia levels, possibly underreported, especially in psychiatric patients.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Microneedles are effective for drug delivery, vaccinations, fluid extraction, and treating hair loss, with advancements in manufacturing like 3D printing.

Bhrungaraj (Eclipta alba) shows potential for drug development based on its traditional uses and pharmacological evidence.

Patients prefer non-drug methods like massage and music to manage chemotherapy side effects, but standardization is needed.

Hair analysis is better than urine and blood for detecting past drug use.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

The drug Albendazole, used for treating parasites, can cause sudden hair loss.

Both new medications and non-drug treatments can effectively manage migraines with fewer side effects.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

Medicinal plants in Kurdistan have potential health benefits and need more research for drug development.

Stopping the use of the drug finasteride can improve sperm count and does not prevent normal conception, but caution is advised when trying to conceive.

Hair antiretroviral concentration is affected by hair type, segment position, housing, drug use, sexual behavior, kidney function, and genetics.

Nanostructured lipid carriers are promising for improving drug delivery in medicine and food.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Nardostachys Jatamansi is an endangered plant with valuable medicinal properties that could lead to safer drug alternatives.

The conclusion is that metformin may be useful for treating various conditions beyond diabetes and that time-tracking analysis is a good way to review drug research.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.